UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000005638
Receipt No. R000006660
Official scientific title of the study Continuous Glucose Monitoring(CGM) in Acute Ischemic Stroke
Date of disclosure of the study information 2011/05/30
Last modified on 2016/11/06 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Continuous Glucose Monitoring(CGM) in Acute Ischemic Stroke
Title of the study (Brief title) Continuous Glucose Monitoring(CGM) in Acute Ischemic Stroke
Region
Japan

Condition
Condition Acute Stroke
Classification by specialty
Neurology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The aim of this study is to examine the effect of continuous glucose level to the infarct expansion and clinical outcome in acute stroke.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Clinical outcome,NIHSS score,complication
the volume of infarction on DWI
Hemorrhagic infarction on T2*
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Device,equipment
Interventions/Control_1 Continuous Glucose Monitoring
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Acute stroke patients on 24h onset
Key exclusion criteria t-PA therapy, endovascular therapy, evacuation of the hematoma

Target sample size 100

Research contact person
Name of lead principal investigator Takashi Shimoyama
Organization Kawasaki Medical School
Division name Department of Stroke Medicine
Address 577 Matsushima, Kurashiki City, Okayama, 701-0192, Japan
TEL
Email

Public contact
Name of contact person
Organization Kawasaki Medical School
Division name Department of Stroke Medicine
Address 577 Matsushima, Kurashiki City, Okayama, 701-0192, Japan
TEL 086-462-1111
Homepage URL
Email

Sponsor
Institute Department of Stroke Medicine, Kawasaki Medical School
Institute
Department

Funding Source
Organization Department of Stroke Medicine, Kawasaki Medical School
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2011 Year 05 Month 30 Day

Progress
Recruitment status Completed
Date of protocol fixation
2011 Year 05 Month 30 Day
Anticipated trial start date
2011 Year 06 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2011 Year 05 Month 24 Day
Last modified on
2016 Year 11 Month 06 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006660